Beat The Denominator

MicroStrategy's new preferred stock, STRC, offers a potential short-term gain, as it is priced at $90 in its offering but is designed to trade near $100. A significant catalyst for Bitcoin is expected in early August, when MicroStrategy plans to use the offering's proceeds for a large BTC purchase. For long-term investors, MSTR common stock represents a leveraged investment in Bitcoin due to the company's core mission of asset accumulation. This strategy continuously funnels capital from traditional finance (TradFi) into Bitcoin, providing consistent buying pressure. The overwhelming demand for the STRC offering signals strong institutional validation for this aggressive Bitcoin acquisition model.

For investors interested in companies holding cryptocurrency, Riot Platforms (RIOT) is presented as a favorite Bitcoin miner well-positioned to grow its holdings. As a more established play, MicroStrategy (MSTR) is trading at a historically low valuation premium, suggesting a potential entry point for a bounce. KULR Technology Group (KULR) offers a unique recovery opportunity, with its recent stock decline seen as a technical overreaction and a full recovery anticipated above $8 per share. For aggressive investors bullish on Ethereum, GameSquare Holdings (GAME) has the highest growth potential but also carries significant small-cap risk. Lastly, those who believe the Solana ecosystem will outperform should consider DeFi Development Corp (DFDV) as the primary way to gain exposure to that theme.

The recent 14% drop in Marathon Digital (MARA) is considered a significant buying opportunity, as the company plans to acquire more Bitcoin with newly raised capital. For long-term investors, Hims & Hers Health (HIMS) is a high-conviction but volatile investment aimed at disrupting the traditional healthcare industry. Conversely, it is recommended to avoid Enphase Energy (ENPH) in the short term due to significant headwinds from tariffs and competition from Tesla. The stock is currently in a "valley of despair," and it may be too early to invest until it potentially bottoms out in the low $30s. A potential long-term strategy for ENPH involves watching for a future entry point, possibly through long-dated call options for late 2027 or 2028.

The upcoming Figma IPO presents a compelling investment as it is rapidly winning the design software market from its rival, Adobe. Consider buying into the IPO, which is expected to price between $25 and $28 per share, backed by 46% year-over-year revenue growth and a strong 132% net dollar retention rate. The company's "sticky" platform and elite customer base suggest a durable competitive advantage over the much slower-growing Adobe (ADBE). Given its strong fundamentals, Figma appears attractively valued compared to peers in the software sector. There is also potential for the stock to be initially mispriced by the market, creating an opportunity for significant upside similar to the recent Circle IPO.

For income-focused investors, consider the new preferred stock STRC as a potential high-yield alternative to T-bills, designed to maintain a stable price around $100. The launch of this instrument is a structurally bullish long-term catalyst for Bitcoin (BTC), as it creates a new source of demand from corporate treasuries. Aggressive investors can view MicroStrategy (MSTR) common stock as a high-risk, leveraged bet on the price of Bitcoin and the success of this new product ecosystem. It is crucial to understand that STRC is designed for stability, while MSTR common stock represents the highest-risk way to invest in the company's strategy. Investors in STRC should monitor the monthly dividend announcements and ensure the price remains within its target $99-$101 range.

MicroStrategy (MSTR) is presented as a compelling long-term holding for Bitcoin bulls, as the company strategically sells its stock at a premium to acquire more BTC. Investors should be cautious in the short-term, as this stock issuance may keep the price range-bound and makes buying call options risky. For those looking to generate income, consider selling put options on MSTR with strike prices in the mid-to-high $300s. This investment thesis is based on a long-term bullish outlook for Bitcoin, with an acquisition phase expected to last for several years. The key catalyst for a significant price increase in MSTR would be the company halting its stock offerings.

Consider buying MicroStrategy (MSTR) stock as a primary way to gain leveraged exposure to Bitcoin within traditional brokerage accounts. The core thesis is that MSTR uses its stock's premium valuation, currently viewed as a "bargain" at 1.66x its Bitcoin holdings, to continuously acquire more Bitcoin for shareholders. For advanced investors, selling cash-secured puts on MSTR is a recommended strategy to generate income or acquire shares at a lower cost basis. Avoid strategies that cap the significant upside, such as selling covered calls or owning the YieldMax MSTR Option Income Strategy ETF (MSTY). Finally, it is suggested to complement this investment by holding some physical Bitcoin (BTC) in a self-custody wallet as a long-term insurance policy.

For investors seeking growth at a reasonable price, consider Zeta Global (ZETA), which is growing faster than its competitors but trades at a cheaper valuation. Alternatively, Viant Technology (DSP) presents a focused play on the rapidly expanding Connected TV advertising market, also at an attractive price. While The Trade Desk (TTD) is the established sector leader, it trades at a significant premium for its market position. The entire ad-tech sector is highly cyclical, influenced by major advertising events. A key strategy is to invest in these stocks during the lead-up to a U.S. presidential election, such as in early 2028, to capitalize on political ad spending.

Consider the recent drop in Oscar Health (OSCR) to around $13 as a buying opportunity, as its strong growth and low valuation may outweigh political headline risks. For a long-term holding, Nubank (NU) is presented as a "coiled spring" whose stock price has not yet reflected its massive customer and revenue growth in Latin America. Invest in The Real Brokerage (REAX) as a high-growth, tech-focused way to benefit from an eventual recovery in the U.S. housing market. The recent Bitcoin dip presents an opportunity in treasury stocks like Japan's MetaPlanet, which

For investors bullish on Ethereum (ETH), consider Sharplink Gaming (SBET) as a leveraged way to gain exposure through the stock market. The company acts as an Ethereum treasury, using its stock's high premium to aggressively accumulate ETH, with a new $5 billion program to fund future purchases. A higher-risk alternative is GameSquare Holdings (GAME), a smaller company new to this strategy that also has a substantial underlying gaming business. Due to its smaller size and existing revenue, GAME may offer higher potential returns for investors willing to accept more uncertainty. Ultimately, both stocks are highly dependent on the price of Ethereum, so your conviction in the underlying asset is the most critical factor before investing.

Consider MicroStrategy (MSTR) as a primary vehicle for gaining leveraged exposure to Bitcoin, as its strategy of issuing stock to acquire BTC provides long-term price support for the asset. A recent shift away from convertible debt is a bullish signal that may reduce selling pressure on MSTR stock. For investors seeking income and a potentially lower-risk approach, investigate the company's unique, non-redeemable preferred shares and debt instruments like STRD, STRF, and CRK. These instruments are backed by Bitcoin collateral and are particularly attractive for long-term holders and the FIRE community due to their structure and potential tax advantages. Finally, investors in Europe should watch for potential Euro-denominated debt offerings, which would represent the next phase of the company's growth strategy.

The recent 30% drop in CorMedix (CRMD) presents a potential entry point, as its core business is growing at 180% with strong margins. For CRMD, the key is to watch the next earnings call for clarification on its recent $100 million capital raise. For higher risk tolerance, BioStem Technologies (BSEM) is an asymmetric bet trading for less than half its annual revenue. The future of BSEM hinges on a critical CMS reimbursement decision expected in October or November, which could result in a multi-bagger return or a significant loss. As a longer-term growth play, consider Delcath Systems (DCTH), which is viewed as a cheap stock with a significant runway as it expands its cancer treatment platform.

The primary investment opportunity is to gain leveraged exposure to Bitcoin through undervalued Bitcoin Treasury Companies. For a core holding, consider MicroStrategy (MSTR), which is viewed as the "blue chip" of the space and is trading at a historically low valuation premium. For higher risk and potential reward, MetaPlanet (OTC) is described as a "steal" after its valuation premium was cut by more than half. The most aggressive play is SmarterWebCompany (OTC), the fastest accumulator of Bitcoin, which is also trading near its cheapest historical levels. These recent price drops present potential buying opportunities for investors who believe in the long-term value of Bitcoin.

For leveraged exposure to Bitcoin, consider MicroStrategy (MSTR), which has historically outperformed BTC itself. With its valuation premium (Price to MNAV) near a one-year low of 1.82, the stock currently presents a compelling entry point for long-term bulls. For a less volatile approach with income, the preferred stock Strike offers a yield of approximately 6.5%. While direct ownership of Bitcoin is a viable long-term strategy, tactical investors may prefer to wait for a significant market dip to buy. Remember that MSTR is a leveraged investment and its value is directly tied to the price of Bitcoin.

For investors with a high-risk tolerance and long-term conviction in Bitcoin, consider MicroStrategy (MSTR) as a leveraged investment vehicle. The company's strategy of using capital markets to continuously acquire more Bitcoin has historically led to significant outperformance against holding BTC directly. For those seeking simpler, unleveraged exposure, a spot ETF like the iShares Bitcoin Trust (IBIT) is the standard option. The underlying thesis is extremely bullish on Bitcoin (BTC) itself, recommending a holding period of at least four years to align with historical cycles. Due to its leveraged nature, an investment in MSTR requires a long-term outlook of 4-10 years and a strong belief in its management's strategy.

Consider investing in select Bitcoin miners as an undervalued play on the AI boom, as their secured power contracts are attractive to power-hungry AI companies. Marathon Digital (MARA) is highlighted as the most undervalued opportunity, with its power infrastructure valued at a significant discount of just $0.29 million per megawatt versus an estimated market cost of $1.5 million. Hut 8 (HUT) is presented as another deeply undervalued option for investors seeking exposure to this theme. For those who prefer a balance of value and quality, Riot Platforms (RIOT) and IREN (IREN) offer attractive valuations combined with more modern mining equipment. The core strategy is to gain exposure to these companies before the market fully recognizes the value of their power access in an AI-driven world.

The primary investment thesis is that ongoing fiat currency debasement makes holding hard assets essential for long-term wealth preservation. Bitcoin (BTC) is presented as the premier hard asset to own, with projected annual growth of over 20% as it enters a new phase of price discovery. For investors seeking leveraged exposure, MicroStrategy (MSTR) is a high-conviction opportunity that aims to outperform Bitcoin by using its corporate structure to aggressively acquire more BTC. The speaker believes MSTR has the potential to grow 8x-9x from its current valuation to become a $1 trillion company. Alternatively, investors in traditional equities should seek out hyper-growth stocks whose revenue growth can significantly outpace both high inflation and Bitcoin's expected returns.

KULR Technology Group (KULR) offers a unique, leveraged investment in Bitcoin while being supported by a strong underlying business. The company is aggressively using its stock to acquire Bitcoin for its treasury, with significant capacity remaining for future purchases. KULR appears undervalued, trading at a low 2.2x Price-to-NAV, as its core space-grade battery business provides a margin of safety not yet recognized by the market. Key catalysts include continued Bitcoin accumulation and increased institutional ownership following its inclusion in the Russell 3000 index. Investors should be aware that the stock is highly volatile due to its complex business model.

For leveraged exposure to Solana (SOL), consider DeFi Development Corp. (DFDV), which uses its high stock premium to aggressively acquire more SOL. A higher-risk, higher-reward strategy involves using its well-developed options market to buy long-term call options (LEAPs) out to December 2026. Similarly, Sharplink Gaming (SBET) offers a leveraged play on Ethereum (ETH), with a potential path to $73 per share if it continues its accretive growth strategy. This investment thesis is based on the growth of the Web3 economy, where ETH and SOL act as digital fuel. Due to a lack of transparency and extreme volatility, it is recommended to avoid Bitmine (BMNR).

Consider Hims & Hers Health (HIMS) for its planned 2026 expansion into Canada, which will be the first market with access to generic semaglutide. This move positions HIMS to capture a significant share of Canada's estimated 20 million potential GLP-1 customers by leveraging its convenient telehealth model. Conversely, Novo Nordisk (NVO) faces a major headwind after losing its Canadian patent for semaglutide due to an administrative error, raising red flags about its internal operations. While competitor LifeMD (LFMD) is valued more cheaply, HIMS is presented as having a superior growth outlook due to this unique Canadian catalyst. The core investment theme is the powerful combination of telehealth platforms and high-demand generic drugs in new markets.